Bioventus Launches Durolane OA Treatment in Taiwan
Bioventus launched DUROLANE® single-injection hyaluronic acid-based osteoarthritis treatment in Taiwan. Jan 04, 2016
Vericel Submits BLA to FDA for MACI for Treatment of Knee Cartilage Defects
Vericel submitted a Biologics License Application to FDA for MACI™ matrix applied characterized autologous cultured chondrocytes, an investigational product intended to treat adult symptomatic cartilage defects of the knee. Jan 04, 2016
Extremities Market Attracts New Players and Innovation
The extremities market generated worldwide product sales of $6.7 billion in 2014, a 9.5% year-over-year increase driven by the absence of payor scrutiny and company saturation, as well as heightened interest from surgeons and patients, according to ORTHOWORLD estimates. Oct 01, 2015
The State and Future of the Orthopaedic Industry: A High Altitude View – FDA: The Fly in the Ointment?
Orthopedics will be more challenging in the future than in the past, but there are opportunities to do well. Oct 15, 2012
Saving Medicine: The Three Cs
American medicine today is truly in crisis, but not for the reasons most often reported. Jul 17, 2012
Emerging Trends in Medical Device Sales
In this changing environment for medical device sales, a new set of best practices can develop superior sales reps. Feb 12, 2012
Accelus Closes Series D Equity Financing
Proceeds will support further U.S. adoption of Accelus’ spinal and robotic-enabled, minimally invasive techniques. Jan 01, 1970
